Tumor M2 pyruvate kinase in renal cell carcinoma. Patient plasma examination;Tumor-M2-pyruvatkinase beim nierenzellkarzinom: Untersuchungen im plasma von patienten

Urologe - Ausgabe A

Volumn 39, Issue 6, 2000, Pages 554-556

  Roigas, J ^a   Schulze, G ^a   Raytarowski, S ^a   Jung, K ^a   Schnorr, D ^a   Loening, S A ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Renal cell carcinoma; Tumor M2 pyruvate kinase

Indexed keywords

PYRUVATE KINASE;

AEROBIC METABOLISM; ARTICLE; CARCINOMA CELL; CELL METABOLISM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GLYCOLYSIS; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY;

CARCINOMA, RENAL CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PYRUVATE KINASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0033695027     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001200050410     Document Type: Article

References (8)

1. L- and M2-pyruvate kinase expression in renal cell carcinomas and their metastases
2. TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions
3. Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas
4. Die bedeutung der pyruvatkinase in der onkologie
5. Value of the serum levels of the tumor marker TUM2-PK in pancreatic cancer
6. The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal cell carcinoma
7. Quantitative determination (ELISA) of pyruvate kinase type tumor M2 - A new tumor marker
8. Marker for renal cell carcinoma (RCC): The dimeric form of pyruvate kinase type M2 (Tu M2-PK)